Breakthrough Trials, Global Health Initiatives and More at #ASH18

This year’s American Society for Hematology (ASH) annual conference had an estimated 31,000 attendees...

With more than 5,000 abstracts presented during the meeting, everyone had their pick of favorite research.

A number of breakthrough clinical trials and research demonstrated the potential for change in the standard of care across a variety of hematologic settings…

Also, attendees tackled global health initiatives, ranging from sickle cell disease...

To improving physician wellness...

...concluding an overall exciting conference!

Illustration by Wendy Gu

More from Op-Med